nodes	percent_of_prediction	percent_of_DWPC	metapath
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0536	0.0536	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—GPR63—Gilles de la Tourette syndrome	0.0525	0.0525	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0458	0.0458	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—DRD3—Gilles de la Tourette syndrome	0.0448	0.0448	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0444	0.0444	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—DRD4—Gilles de la Tourette syndrome	0.0434	0.0434	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0414	0.0414	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—DRD2—Gilles de la Tourette syndrome	0.0405	0.0405	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0385	0.0385	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—DRD3—Gilles de la Tourette syndrome	0.0376	0.0376	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0373	0.0373	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—DRD4—Gilles de la Tourette syndrome	0.0365	0.0365	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.0348	0.0348	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—DRD2—Gilles de la Tourette syndrome	0.034	0.034	CbGpPWpGaD
Formoterol—ADRB1—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.029	0.029	CbGpPWpGaD
Formoterol—ADRB2—Monoamine GPCRs—HTR2A—Gilles de la Tourette syndrome	0.0283	0.0283	CbGpPWpGaD
Formoterol—ADRB1—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0244	0.0244	CbGpPWpGaD
Formoterol—ADRB2—Arf6 signaling events—MET—Gilles de la Tourette syndrome	0.0241	0.0241	CbGpPWpGaD
Formoterol—ADRB2—Amine ligand-binding receptors—HTR2A—Gilles de la Tourette syndrome	0.0238	0.0238	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—DRD3—Gilles de la Tourette syndrome	0.0199	0.0199	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—DRD4—Gilles de la Tourette syndrome	0.0193	0.0193	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Other—HTR2A—Gilles de la Tourette syndrome	0.0126	0.0126	CbGpPWpGaD
Formoterol—CYP2A6—NRF2 pathway—SLC6A3—Gilles de la Tourette syndrome	0.0112	0.0112	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00883	0.00883	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD3—Gilles de la Tourette syndrome	0.00864	0.00864	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00857	0.00857	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD4—Gilles de la Tourette syndrome	0.00838	0.00838	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00798	0.00798	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—DRD2—Gilles de la Tourette syndrome	0.00781	0.00781	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.00756	0.00756	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD3—Gilles de la Tourette syndrome	0.0074	0.0074	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00734	0.00734	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	0.00718	0.00718	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00684	0.00684	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	0.00669	0.00669	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00576	0.00576	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	0.00564	0.00564	CbGpPWpGaD
Formoterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00559	0.00559	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00559	0.00559	CbGpPWpGaD
Formoterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	0.00547	0.00547	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	0.00547	0.00547	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.00521	0.00521	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	0.0051	0.0051	CbGpPWpGaD
Formoterol—CYP2A6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00483	0.00483	CbGpPWpGaD
Formoterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00479	0.00479	CbGpPWpGaD
Formoterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	0.00469	0.00469	CbGpPWpGaD
Formoterol—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00365	0.00365	CbGpPWpGaD
Formoterol—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	0.00357	0.00357	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00326	0.00326	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	0.00318	0.00318	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00316	0.00316	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	0.00309	0.00309	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00296	0.00296	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00294	0.00294	CbGpPWpGaD
Formoterol—CYP2C19—Metabolism—HDC—Gilles de la Tourette syndrome	0.00294	0.00294	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	0.00289	0.00289	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	0.00288	0.00288	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00287	0.00287	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	0.00281	0.00281	CbGpPWpGaD
Formoterol—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	0.00271	0.00271	CbGpPWpGaD
Formoterol—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	0.00268	0.00268	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00267	0.00267	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	0.00262	0.00262	CbGpPWpGaD
Formoterol—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00206	0.00206	CbGpPWpGaD
Formoterol—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	0.00202	0.00202	CbGpPWpGaD
Formoterol—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00187	0.00187	CbGpPWpGaD
Formoterol—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	0.00183	0.00183	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00175	0.00175	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	0.00171	0.00171	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.0017	0.0017	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	0.00166	0.00166	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00158	0.00158	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	0.00154	0.00154	CbGpPWpGaD
Formoterol—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00111	0.00111	CbGpPWpGaD
Formoterol—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	0.00108	0.00108	CbGpPWpGaD
